日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Conserved stromal EMT program controls regenerative capacity of mesenchymal stromal cells across multiple tissues.

保守的基质 EMT 程序控制着多种组织中间充质基质细胞的再生能力。

Kim Jin-A, Park Bong-Woo, Lee Hae-Ri, Jung Gyung-Ah, Lee Susie, Sim Woo-Sup, Lee Hyemi, Kim Jihoon, Shin Sungho, Lee Cheolju, Park Silvia, Kang Young-Ju, Lee Jong-Wook, Kim Hee-Je, Kwon Yunhee Kim, Park Hun-Jun, Oh Il-Hoan

Serial next-generation sequencing for detecting germline predisposition in acute myeloid leukemia

利用新一代测序技术检测急性髓系白血病中的种系易感性

Ahn, Jae-Sook; Park, Joo Heon; Lee, ChangSun; Song, Ik-Chan; Kim, Mi Yeon; Sohn, Sang Kyun; Yhim, Ho-Young; Park, Yong; Kim, Inho; Shin, Ho-Jin; Park, Seong-Kyu; Kim, Sung-Hyun; Cheong, June-Won; Lee, Ho Sup; Lee, Hyewon; Bae, Sung Hwa; Choi, Yunsuk; Lee, Hong-Ghi; Do, Young Rok; Han, Jae Joon; Kim, Min Kyoung; Park, Silvia; Kim, Hee-Je; Kim, Hyeoung-Joon; Working Party, Korean Aml/Mds

Clinical outcomes of WHO2022 and ICC MDS entities with risk stratification by IPSS-R and IPSS-M

WHO2022 和 ICC MDS 实体的临床结局,并根据 IPSS-R 和 IPSS-M 进行风险分层

Kwag, Daehun; Bae, Byunggyu; Jung, Jin; Kim, Hoon Seok; Lee, Jong-Mi; Ahn, Ari; Yoon, Ji Sang; Park, So Yeon; Park, Silvia; Kim, Myungshin; Kim, Yoo-Jin; Kim, Yonggoo

Individualized decitabine dosing for post-HSCT maintenance in MDS and secondary AML from MDS: long-term outcomes from the PODAC trial and matched controls

针对MDS和MDS继发性AML患者,采用个体化地西他滨剂量进行HSCT后维持治疗:PODAC试验及匹配对照组的长期疗效

Park, Silvia; Choi, Suein; Han, Seunghoon; Kim, Yoo-Jin

Donor type and post-transplant outcomes in anti-thymocyte globulin based allogeneic transplantation for myelodysplastic syndromes

供体类型与基于抗胸腺细胞球蛋白的异基因移植治疗骨髓增生异常综合征的移植后结果

Park, So Yeon; Lee, Hyeji; Kwag, Daehun; Min, Gi June; Park, Sung Soo; Yoon, Jae-Ho; Lee, Sung-Eun; Cho, Byung Sik; Eom, Ki-Seong; Kim, Hee-Je; Min, Chang-Ki; Cho, Seok-Goo; Park, Silvia; Kim, Yoo-Jin

Poor prognostic implication of CDKN2 deletion in adult patients with Philadelphia chromosome-positive ALL

CDKN2缺失对费城染色体阳性急性淋巴细胞白血病成人患者预后不良具有重要意义

Park, So Yeon; Kwag, Daehun; Jung, Jin; Min, Gi June; Park, Sung-Soo; Park, Silvia; Lee, Sung-Eun; Cho, Byung-Sik; Eom, Ki-Seong; Kim, Yoo-Jin; Kim, Hee-Je; Min, Chang-Ki; Cho, Seok-Goo; Kim, Yonggoo; Kim, Myungshin; Lee, Seok; Yoon, Jae-Ho

BCR::ABL1-positive acute lymphoblastic leukemia as a high-risk feature of central nervous system relapse after allogeneic hematopoietic cell transplantation

BCR::ABL1阳性急性淋巴细胞白血病是异基因造血干细胞移植后中枢神经系统复发的高危因素

Lee, Jong Hyuk; Kwag, Daehun; Min, Gi-June; Park, Sung-Soo; Park, Silvia; Lee, Sung-Eun; Cho, Byung-Sik; Eom, Ki-Seong; Kim, Yoo-Jin; Kim, Hee-Je; Min, Chang-Ki; Cho, Seok-Goo; Lee, Seok; Yoon, Jae-Ho

Analysis of chromatin accessibility associated with azacitidine response in higher-risk myelodysplastic neoplasms

分析与高危骨髓增生异常肿瘤中阿扎胞苷反应相关的染色质可及性

Kim, Dayoung; Park, Silvia; Kwon, Yong-Rim; Yoon, Heejei; Cho, Byung-Sik; Baek, Inwha; Kang, Joo H; Park, Tae-Eun; Corces, M Ryan; Kim, Hee-Je; Kim, Yoo-Jin; Cho, Seung Woo

Influence of Organ-Specific Extranodal Involvement on Survival Outcomes in Stage IV Diffuse Large B-Cell Lymphoma

器官特异性结外受累对IV期弥漫性大B细胞淋巴瘤生存结局的影响

Kim, Tong-Yoon; Kim, Tae-Jung; Han, Eun Ji; Min, Gi June; Park, Sung-Soo; Park, Silvia; Yoon, Jae-Ho; Lee, Sung-Eun; Cho, Byung-Sik; Eom, Ki-Seong; Kim, Yoo-Jin; Kim, Hee-Je; Lee, Seok; Min, Chang-Ki; Lee, Jong-Wook; Jeon, Youngwoo; Cho, Seok-Goo

Atypical features of hepatic veno-occlusive disease/sinusoidal obstruction syndrome after inotuzumab ozogamicin in adult patients with acute lymphoblastic leukemia

成人急性淋巴细胞白血病患者接受inotuzumab ozogamicin治疗后出现肝静脉闭塞病/肝窦阻塞综合征的非典型特征

Sung, Kyung-Hun; Kwag, Daehun; Min, Gi June; Park, Sung-Soo; Park, Silvia; Lee, Sung-Eun; Cho, Byung-Sik; Eom, Ki-Seong; Kim, Yoo-Jin; Kim, Hee-Je; Min, Chang-Ki; Cho, Seok-Goo; Lee, Seok; Yoon, Jae-Ho